ROLE OF GLP-1 RECEPTOR AGONISTS IN THE TREATMENT CONTINUUM OF TYPE 2 DIABETES

Volume 1, Issue 8.

Rajesh Garg, MD, Assistant Professor of Medicine, covers the important topic of the role of GLP-1 Receptor Agonists in the Treatment Continuum of Type 2 Diabetes in the format of case-study scenarios for the clinical practice.

Strategies and Devices for Improving Self-Monitoring

Volume 1, Issue 6.

Susan Porter, MSN, CRNP, CDE, Clinical Nurse Practitioner and Certified Diabetes Educator, covers the important topic of strategies and devices for improving self-monitoring in the format of case-study scenarios for the clinical practice.

CVD RISK FACTORS IN PATIENTS WITH T2D

Volume 1, Issue 4.

Om Ganda, MD, Associate Professor of Medicine at Harvard Medical School, and Senior Physician and Director, Lipid Clinic, and Chair, Clinical Oversight Committee at the Joslin Diabetes Center in Boston, Massachusetts discusses the important topic of CVD risk factors in patients with T2D in the format of case-study scenarios for the clinical practice.

Strategies For Intensifying Therapy For Glycemic Control

Volume 1, Issue 2.

Nestoras Mathioudakis, MD, Assistant Professor of Medicine, Division of Endocrinology, Diabetes, and Metabolism and Associate Director, Inpatient Diabetes Management at the Johns Hopkins University School of Medicine discusses glycemic control and strategies to intensify therapy in the format of case-study scenarios for the clinical practice.